IP

Ian Peikon

Co-Founder & Co-Chief Executive Officer

Seattle, Washington

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $50,000,000.00

  • Target Investment:

    $10,000,000.00

Skills

Molecular Biology
Neuroscience
Biotechnology
Start-ups
Biomedical Engineering
Electrophysiology
Fluorescence Microscopy
Confocal Microscopy
Genetics
Matlab
Cell Biology
C++
Computational Biology
Bioinformatics
Synthetic Biology
Protein Purification
Western Blotting
PCR
Emulsion PCR
Cell Culture

Education

Investments

Cajal Neuroscience

Seed

Total Funding: $96M

Work Experience

Cajal Neuroscience

2020

  • Co-Founder & Co-Chief Executive Officer

    2020

Plexium

2022

  • Board Member

    2022

Lux Capital

2019

  • Venture Partner

    2019

VNV Bio

2018 - 2022

  • Co-Founder & SAB Member

    2018 - 2022

    non-viral gene therapy delivery systems - acquired by Aera Therapeutics

Kallyope

2015 - 2019

  • Co-Founder & Director, Platform Biology & Technology

    2015 - 2019

    I was part of the founding team of Kallyope and led the platform for new target discovery.